The Jets NRL bid explain why, after 16 years, they have not given up hope of being granted an expansion licence.

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

RHI Magnesita, the leading global supplier of heat management solutions, have released their Q324 financial results ...

One recommendation is for an external “player draft”, where young players with no professional history in the NRL would be ...

Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with solid ...

Vitaly Nesis also informed President Tokayev about the Company's acquisition of a 55% interest in Syrymbet, an undeveloped polymetallic deposit located in North-Kazakhstan region.

A team of researchers from Xi’an Jiaotong University, Tianmushan Laboratory, and the National University of Singapore has pioneered a new method for crafting an ultra-strong, ductile alloy using 3D ...

Papua New Guinea is already locked in as part of the expansion process after the NRL struck a $600 million partnership with ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...

Nathan Cleary successfully underwent Latarjet surgery on his troublesome shoulder on Monday but now faces a race against the ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...